ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $61,695 | -92.4% | 2,296 | -89.9% | 0.00% | -100.0% |
Q2 2023 | $814,190 | +48.0% | 22,832 | +5.4% | 0.00% | – |
Q1 2023 | $549,986 | -40.6% | 21,653 | -5.1% | 0.00% | -100.0% |
Q4 2022 | $925,335 | +19.7% | 22,814 | -2.5% | 0.00% | 0.0% |
Q3 2022 | $773,000 | -1.4% | 23,399 | +5.1% | 0.00% | 0.0% |
Q2 2022 | $784,000 | -24.8% | 22,254 | -1.9% | 0.00% | 0.0% |
Q1 2022 | $1,043,000 | -30.8% | 22,684 | -0.2% | 0.00% | 0.0% |
Q4 2021 | $1,507,000 | +8.3% | 22,727 | +1.9% | 0.00% | 0.0% |
Q3 2021 | $1,392,000 | -25.8% | 22,295 | -1.6% | 0.00% | -50.0% |
Q2 2021 | $1,876,000 | +25.2% | 22,649 | +0.2% | 0.00% | +100.0% |
Q1 2021 | $1,499,000 | -13.1% | 22,614 | +0.7% | 0.00% | -50.0% |
Q4 2020 | $1,724,000 | +86.4% | 22,458 | +4.5% | 0.00% | +100.0% |
Q3 2020 | $925,000 | +963.2% | 21,495 | +969.4% | 0.00% | – |
Q2 2020 | $87,000 | +42.6% | 2,010 | -5.6% | 0.00% | – |
Q1 2020 | $61,000 | -60.1% | 2,130 | -11.3% | 0.00% | – |
Q4 2019 | $153,000 | +61.1% | 2,402 | -28.7% | 0.00% | – |
Q3 2019 | $95,000 | +28.4% | 3,369 | +20.3% | 0.00% | – |
Q2 2019 | $74,000 | +825.0% | 2,801 | +600.2% | 0.00% | – |
Q3 2018 | $8,000 | +300.0% | 400 | +36.1% | 0.00% | – |
Q2 2016 | $2,000 | – | 294 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,303 | $54,386,000 | 28.54% |
JOHNSON & JOHNSON | 3,260,869 | $216,196,000 | 24.61% |
ACT CAPITAL MANAGEMENT, LLC | 210,500 | $13,956,000 | 10.09% |
Aquilo Capital Management, LLC | 700,426 | $46,438,000 | 5.27% |
WEALTH EFFECTS LLC | 145,960 | $9,677,000 | 4.02% |
Evolutionary Tree Capital Management, LLC | 115,580 | $7,663,000 | 3.68% |
ACUTA CAPITAL PARTNERS, LLC | 105,500 | $6,995,000 | 2.94% |
Privium Fund Management B.V. | 204,393 | $13,766,000 | 2.73% |
L1 Capital Pty Ltd | 292,735 | $19,408,000 | 2.24% |
Avidity Partners Management LP | 875,000 | $58,013,000 | 1.23% |